DermaFloat is the first patient support system that prevents pressure ulcers by removing surface contact entirely. No compression. No shear. No turning schedules.
Every existing surface — from basic foam to $50K alternating-pressure mattresses — still compresses tissue. DermaFloat takes a fundamentally different approach.
Pressure ulcers form when sustained pressure cuts off blood flow to tissue. Every mattress, no matter how advanced, still applies pressure. The only way to truly prevent them is to remove the contact surface.
Q2H repositioning is the standard of care, but compliance rates are as low as 30-50%. Staff shortages, night shifts, and patient resistance make consistent turning nearly impossible at scale.
Hospital-acquired pressure ulcers cost the US healthcare system $26 billion annually. CMS no longer reimburses for Stage III/IV facility-acquired PUs. Prevention isn't just clinical — it's financial survival.
DermaFloat uses a medical-grade mesh suspension system that cradles the patient above the frame — distributing weight across the mesh without any point-pressure contact.
A breathable, medical-grade mesh is tensioned across an adjustable frame, creating a floating support surface with zero hard contact points.
The patient's weight is distributed across thousands of mesh contact points, keeping interface pressure below capillary closing pressure at every location.
The open mesh design allows 360-degree airflow around the patient's body, managing moisture and temperature — two critical factors in skin breakdown.
See exactly how DermaFloat compares to the surface technologies your facility is currently using.
| Feature | Standard Foam | Alternating Pressure | Low-Air-Loss | Manual Turning | DermaFloat |
|---|---|---|---|---|---|
| Interface Pressure | 25-40 mmHg | 15-30 mmHg (cycled) | 15-25 mmHg | Varies (0 when off-loaded) | ✓ <5 mmHg continuous |
| Eliminates Shear | ✗ No | ✗ No | ~ Partial | ✗ No (causes shear) | ✓ Yes — mesh conforms |
| Staff Time Required | Q2H turning + skin checks | Daily checks | Daily checks + maintenance | Q2H turning (20 min each) | ✓ Minimal — monitoring only |
| Airflow / Moisture | ✗ Traps heat | ~ Some airflow | ✓ Good airflow | ✗ N/A | ✓ 360° open airflow |
| Noise Level | Silent | Pump noise (40-55 dB) | Blower noise (35-45 dB) | N/A (staff disruption) | ✓ Silent |
| Power Required | None | Continuous | Continuous | None | ✓ None (passive system) |
| Estimated Monthly Cost | $50-150 | $1,500-3,000 | $2,000-4,000 | $2,400+ (staff time) | ✓ Competitive — contact us |
The clinical and financial case for eliminating pressure ulcers — not just managing them.
Pressure ulcers are a leading contributor to mortality in long-term care patients. They dramatically increase infection risk and complicate recovery from other conditions.
A single Stage IV pressure ulcer can cost $70,000+ to treat — and CMS does not reimburse for facility-acquired cases. Prevention isn't just better care, it's better economics.
Studies show that manual turning schedules are followed only 30-50% of the time. Staff shortages, patient refusal, and overnight gaps make consistent repositioning unreliable.
Unlike turning schedules or alternating pressure cycles, DermaFloat provides continuous, passive pressure elimination. No staff intervention required. No power. No gaps in protection.
See how DermaFloat can reduce pressure ulcer incidence, lower costs, and free up your care team. We'll walk you through the system, discuss your facility's needs, and provide a custom assessment.
We'll respond within 24 hours.
Thank you. Our team will reach out within 24 hours to schedule your personalized demo and facility assessment.
Join the facilities rethinking pressure ulcer prevention. Request your demo today.
Request a Demo →